Dr. Annemieke Aartsma-Rus played an important role in the development of the antisense mediated exon skipping therapy for Duchenne muscular dystrophy during her PhD research (2000-2004), at the Leiden University Medical Center, Department of Human Genetics (the Netherlands). As of December 2007 she became leader of the “DMD exon skip group” first, as assistant professor and currently as associate professor at the Department of Human Genetics.
Thus far, Annemieke has published over 50 papers and 9 book chapters, as well as 11 patents and has edited one book. She has given many invited lectures at meetings, symposiums and workshops as well as patient/parent organizations meetings. She has created and maintains a website on exon skipping, containing a dedicated section for patients and parents as well as patient-friendly pages on therapeutic approaches for the TREAT-NMD website. In 2011, she received the Duchenne Award from the Dutch Duchenne Parent Project in recognition of this work and her dedication to the Duchenne field.
She is Chair of the Executive Board of the TREAT-NMD alliance and coordinator of a COST action to accelerate the clinical implementation of exon skipping approaches for rare disease.